MXPA05003718A - Compuestos x-nitro, sus composiciones farmaceuticas y sus usos. - Google Patents
Compuestos x-nitro, sus composiciones farmaceuticas y sus usos.Info
- Publication number
- MXPA05003718A MXPA05003718A MXPA05003718A MXPA05003718A MXPA05003718A MX PA05003718 A MXPA05003718 A MX PA05003718A MX PA05003718 A MXPA05003718 A MX PA05003718A MX PA05003718 A MXPA05003718 A MX PA05003718A MX PA05003718 A MXPA05003718 A MX PA05003718A
- Authority
- MX
- Mexico
- Prior art keywords
- nitro compounds
- pharmaceutical compositions
- uses therof
- therof
- nitro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
La presente invencion proporciona compuestos X-nitro, composiciones farmaceuticas de compuestos X-nitro y metodos de empleo de compuestos X-nitro y composiciones farmaceuticas de los mismos para tratar o evitar enfermedades o desordenes caracterizados por proliferacion de celulas anormal, tales como cancer, inflamacion, enfermedad cardiovascular y enfermedad autoimmune.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41693602P | 2002-10-07 | 2002-10-07 | |
US46478203P | 2003-04-22 | 2003-04-22 | |
PCT/US2003/032022 WO2004032864A2 (en) | 2002-10-07 | 2003-10-07 | X-nitro compounds, pharmaceutical compositions thereof and uses therof |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05003718A true MXPA05003718A (es) | 2005-09-30 |
Family
ID=32096173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05003718A MXPA05003718A (es) | 2002-10-07 | 2003-10-07 | Compuestos x-nitro, sus composiciones farmaceuticas y sus usos. |
Country Status (7)
Country | Link |
---|---|
US (2) | US20040167212A1 (es) |
EP (1) | EP1556056A4 (es) |
JP (1) | JP2006505620A (es) |
AU (1) | AU2003282534A1 (es) |
CA (1) | CA2501625A1 (es) |
MX (1) | MXPA05003718A (es) |
WO (1) | WO2004032864A2 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070135380A1 (en) | 2005-08-12 | 2007-06-14 | Radiorx, Inc. | O-nitro compounds, pharmaceutical compositions thereof and uses thereof |
US7507842B2 (en) | 2005-08-12 | 2009-03-24 | Radiorx, Inc. | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof |
US8471041B2 (en) * | 2010-02-09 | 2013-06-25 | Alliant Techsystems Inc. | Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same |
US8664247B2 (en) | 2011-08-26 | 2014-03-04 | Radiorx, Inc. | Acyclic organonitro compounds for use in treating cancer |
US20140308260A1 (en) | 2011-10-07 | 2014-10-16 | Radiorx, Inc. | Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products |
ES2935573T3 (es) | 2011-10-07 | 2023-03-08 | Epicentrx Inc | Compuestos de organonitro tioéter y usos médicos de estos |
US10342778B1 (en) | 2015-10-20 | 2019-07-09 | Epicentrx, Inc. | Treatment of brain metastases using organonitro compound combination therapy |
US9987270B1 (en) | 2015-10-29 | 2018-06-05 | Epicentrix, Inc. | Treatment of gliomas using organonitro compound combination therapy |
JP6931004B2 (ja) | 2016-01-11 | 2021-09-01 | エピセントアールエックス,インコーポレイテッド | 2−ブロモ−1−(3,3−ジニトロアゼチジン−1−イル)エタノンの静脈内投与のための組成物および方法 |
WO2018071741A1 (en) | 2016-10-14 | 2018-04-19 | Epicentrix, Inc. | Sulfoxyalkyl organonitro and related compounds and pharmaceutical compositions for use in medicine |
MX2020000265A (es) | 2017-07-07 | 2020-07-22 | Epicentrx Inc | Composiciones para la administración parenteral de agentes terapéuticos. |
WO2019164593A2 (en) | 2018-01-08 | 2019-08-29 | Epicentrx, Inc. | Methods and compositions utilizing rrx-001 combination therapy for radioprotection |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4935450A (en) * | 1982-09-17 | 1990-06-19 | Therapeutical Systems Corporation | Cancer therapy system for effecting oncolysis of malignant neoplasms |
GB8504253D0 (en) * | 1985-02-19 | 1985-03-20 | Ici Plc | Electrostatic spraying apparatus |
US4756539A (en) * | 1986-06-26 | 1988-07-12 | John Sneddon | Collapsible golf buggy with seat |
GB8728418D0 (en) * | 1987-12-04 | 1988-01-13 | Jenkins T C | Nitro-substituted aromatic/hetero-aromatic compounds for use in cancer treatment |
DE3815221C2 (de) * | 1988-05-04 | 1995-06-29 | Gradinger F Hermes Pharma | Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen |
US5693794A (en) * | 1988-09-30 | 1997-12-02 | The United States Of America As Represented By The Secretary Of The Navy | Caged polynitramine compound |
JP2659614B2 (ja) * | 1990-11-13 | 1997-09-30 | 株式会社日立製作所 | 表示制御装置 |
US5698155A (en) * | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
US5691371A (en) * | 1993-05-25 | 1997-11-25 | Auckland Uniservices Limited | Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents |
DE69605025T2 (de) * | 1995-03-14 | 2000-07-20 | Siemens Ag | Ultraschallzerstäuber mit abnehmbarer präzisionsdosiereinheit |
US5970974A (en) * | 1995-03-14 | 1999-10-26 | Siemens Aktiengesellschaft | Dosating unit for an ultrasonic atomizer device |
US5580988A (en) * | 1995-05-15 | 1996-12-03 | The United States Of America As Represented By The Secretary Of The Army | Substituted azetidines and processes of using them |
US5898038A (en) * | 1996-03-19 | 1999-04-27 | Board Of Regents, The University Of Texas System | Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors |
US5954047A (en) * | 1997-10-17 | 1999-09-21 | Systemic Pulmonary Development, Ltd. | Methods and apparatus for delivering aerosolized medication |
DK1098641T3 (en) * | 1998-07-27 | 2016-08-15 | St Jude Pharmaceuticals Inc | Chemically induced intracellular hyperthermia |
US6448253B1 (en) * | 1998-09-16 | 2002-09-10 | King Pharmaceuticals Research And Development, Inc. | Adenosine A3 receptor modulators |
US6245799B1 (en) * | 1999-11-08 | 2001-06-12 | American Home Products Corp | [(Indol-3-yl)-cycloalkyl]-3-substituted azetidines for the treatment of central nervous system disorders |
DE10111049A1 (de) * | 2001-03-06 | 2002-09-12 | Beiersdorf Ag | Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen, zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter trockener Haut |
CA2491127A1 (en) * | 2002-07-03 | 2004-01-15 | Nitromed, Inc. | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
-
2003
- 2003-10-07 AU AU2003282534A patent/AU2003282534A1/en not_active Abandoned
- 2003-10-07 MX MXPA05003718A patent/MXPA05003718A/es not_active Application Discontinuation
- 2003-10-07 JP JP2005501143A patent/JP2006505620A/ja active Pending
- 2003-10-07 EP EP03774724A patent/EP1556056A4/en not_active Withdrawn
- 2003-10-07 US US10/681,855 patent/US20040167212A1/en not_active Abandoned
- 2003-10-07 WO PCT/US2003/032022 patent/WO2004032864A2/en active Application Filing
- 2003-10-07 CA CA002501625A patent/CA2501625A1/en not_active Abandoned
-
2009
- 2009-04-23 US US12/429,093 patent/US20090291935A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090291935A1 (en) | 2009-11-26 |
EP1556056A4 (en) | 2008-08-06 |
EP1556056A2 (en) | 2005-07-27 |
US20040167212A1 (en) | 2004-08-26 |
AU2003282534A1 (en) | 2004-05-04 |
CA2501625A1 (en) | 2004-04-22 |
JP2006505620A (ja) | 2006-02-16 |
WO2004032864A3 (en) | 2004-06-24 |
WO2004032864A2 (en) | 2004-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007022225A3 (en) | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof | |
HUS2100051I1 (hu) | Kompozíciók és eljárások sejtproliferációs rendellenességek kezelésére | |
TNSN07161A1 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
MX2008001982A (es) | Compuestos nitro-o, sus composiciones farmaceuticas y sus usos. | |
MX2009006339A (es) | Compuestos y composiciones como inhibidores de actividad de receptor 1 de cannabinoide. | |
WO2004041203A3 (en) | Gemcitabine prodrugs, pharmaceutical compositions and uses thereof | |
TW200510416A (en) | P38 inhibitors and methods of use thereof | |
ZA200701661B (en) | Isoindoline compounds and methods of making and using the same | |
MX2007004551A (es) | Compuestos tiadiazol y metodos de uso. | |
MY158162A (en) | 5-membered heterocycle-based p38 kinase inhibitors | |
EA200800763A1 (ru) | Терапевтические композиции, содержащие гиалуроновую кислоту и терапевтические антитела, а также способы лечения | |
GB0222495D0 (en) | Compounds | |
MXPA04002070A (es) | Compuestos de indazol sustituidos para el tratamiento de la inflamacion. | |
UA83194C2 (ru) | Производные пиримидина и их применение как модуляторов св2 | |
SG170024A1 (en) | Imidazole-based compounds, compositions comprising them and methods of their use | |
TW200631583A (en) | Substituted pteridines for the treatment of inflammatory diseases | |
IL171974A0 (en) | Tetrahydrocarbazole derivatives and their pharmaceutical use | |
TW200510367A (en) | Novel lapachone compounds, their preparation, and the use thereof | |
MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
MXPA05003718A (es) | Compuestos x-nitro, sus composiciones farmaceuticas y sus usos. | |
PT1492773E (pt) | Compostos de 4-(heterociclilo)-benzenossulfoximinapara o tratamento da inflamação | |
TW200716153A (en) | Mitotic kinesin inhibitors and methods of use thereof | |
WO2003105753A3 (en) | METHODS AND COMPOSITIONS FOR GRAFTING FUNCTIONAL LOOPS INTO A PROTEIN | |
TW200603791A (en) | Compounds and compositions as cathepsin S inhibitors | |
GB2430365B (en) | High-purity texaphyrin metal complexes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |